Cohort studycited by the Tayebat archiveabstract only checked A-BAR-17 standard review

UK: fractures after weight-loss surgery

Risk of fracture after bariatric surgery in the United Kingdom: population based, retrospective cohort study.

Overview

Lalmohamed A et al.. BMJ 2012 · PMID 22867649 · DOI 10.1136/bmj.e5085

No significant increase in fractures in the first 2-3 years.

Does the study support the specific claim? No · Methodological quality: moderate

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Fracture

How was the study done?

Matched cohort

How many people, animals or samples were studied?

12,521

What was actually found?

No increase

How large was the observed effect?

RR 0.89

What do the results mean in everyday life?

Short-term reassuring

What are the study's limitations?

Short follow-up

What does it say about Elawady's specific claim?

Limits claim

Do the results apply to Germany and Europe?

European

What can explicitly not be concluded from this study?

Long-term risk

Scientific in-depth review

1. Full reference

Authors
Lalmohamed A, de Vries F, Bazelier MT, Cooper A, van Staa TP, Cooper C, Harvey NC
Journal
BMJ
Year
2012
Identifier
PMID 22867649 DOI 10.1136/bmj.e5085 · PMC3413006
Verification
verified – PubMed E-utilities efetch, 2026-10-25
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

COI: Competing interests: All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: support from the International Osteoporosis Foundation and SERVIER for the submitted work; AL, FV, MB, and TS are employed by the Division of Pharmacoepidemiology and Clinical Pharmacology at Utrecht Institute for Pharmaceutical Sciences, which has received unrestricted research funding from the Netherlands Organisation for Health Research and Development, Dutch Health Care Insurance Board, Royal Dutch Pharmacists Association, private-publicly funded Top Institute Pharma (www.tipharma.nl, which includes cofunding from universities, government, and industry), EU Innovative Medicines Initiative, EU 7th Framework Program, Dutch Medicines Evaluation Board, Dutch Ministry of Health and industry (including GlaxoSmithKline, Pfizer); no financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work. | Grants: none listed

2. Research question

Fracture risk after bariatric surgery

3. Study design and population

Study design
Cohort study – Population-based retrospective matched cohort (UK CPRD)
Population

UK adults BMI>=30

Country

UK

Period

1987-2010

Sample size

2079 surgery vs 10,442 controls

4. Methods and endpoints

Exposure / intervention

Bariatric surgery

Comparator

Matched obese controls

Endpoints

Any, osteoporotic, non-osteoporotic fracture

5. Actual results

Results

8.8 vs 8.2 per 1000 person-years; adjusted RR 0.89 (0.60-1.33); non-significant trend after 3-5 years.

Absolute risks

8.8 vs 8.2 per 1000 PY

Authors' conclusion

No significant effect on fracture risk in first years; longer-term adverse effect not excluded.

6. Strengths

  • Population-based

7. Weaknesses

  • Mean follow-up 2.2 years
  • Many banding procedures likely

8. Risk of bias

Orienting tool
ROBINS-E
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
some concerns

9. Assessment of the statistical interpretation

10. Relevance to the specific claim

Limits C-BAR-06.

11. Independent contrary findings

12. Transferability to Germany and Europe

European.

13. Overall methodological judgement

Short follow-up; null result.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualitymoderate
Risk of biassome concerns
Precision of resultslow
Directnessdirect
Reproducibilitypartly replicated
Consistency with the overall evidencemixed
Regional transferabilityhigh
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

15. Linked fact checks

Use by the Tayebat archive

Note: according to the archive, the studies were compiled by the archive operators. Whether Dr. Elawady himself cited this study is not established.

What the archive says about the study

Listed in the archive bibliography only; the archive gives no specific interpretation.

A. What was actually studied?

Fracture risk

B. What did the authors find?

No significant increase at 2.2 years

C. What conclusions do the authors themselves draw?

Reassuring short-term

D. What does the archive derive from it?

Listed under bone harm.

E. Is this derivation scientifically justified?

The study does not support increased fracture risk in the short term; it limits the archive's bone claim.

Adequacy of the interpretation (by the archive)
not applicable